Asset Details
Do you wish to reserve the book?
Impact of Enterobius vermicularis infection and mebendazole treatment on intestinal microbiota and host immune response
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Impact of Enterobius vermicularis infection and mebendazole treatment on intestinal microbiota and host immune response
Do you wish to request the book?
Impact of Enterobius vermicularis infection and mebendazole treatment on intestinal microbiota and host immune response
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Impact of Enterobius vermicularis infection and mebendazole treatment on intestinal microbiota and host immune response
2017
Overview
Previous studies on the association of enterobiasis and chronic inflammatory diseases have revealed contradictory results. The interaction of Enterobius vermicularis infection in particular with gut microbiota and induced immune responses has never been thoroughly examined.
In order to answer the question of whether exposure to pinworm and mebendazole can shift the intestinal microbial composition and immune responses, we recruited 109 (30 pinworm-negative, 79 pinworm-infected) first and fourth grade primary school children in Taichung, Taiwan, for a gut microbiome study and an intestinal cytokine and SIgA analysis. In the pinworm-infected individuals, fecal samples were collected again at 2 weeks after administration of 100 mg mebendazole. Gut microbiota diversity increased after Enterobius infection, and it peaked after administration of mebendazole. At the phylum level, pinworm infection and mebendazole deworming were associated with a decreased relative abundance of Fusobacteria and an increased proportion of Actinobacteria. At the genus level, the relative abundance of the probiotic Bifidobacterium increased after enterobiasis and mebendazole treatment. The intestinal SIgA level was found to be lower in the pinworm-infected group, and was elevated in half of the mebendazole-treated group. A higher proportion of pre-treatment Salmonella spp. was associated with a non-increase in SIgA after mebendazole deworming treatment.
Childhood exposure to pinworm plus mebendazole is associated with increased bacterial diversity, an increased abundance of Actinobacteria including the probiotic Bifidobacterium, and a decreased proportion of Fusobacteria. The gut SIgA level was lower in the pinworm-infected group, and was increased in half of the individuals after mebendazole deworming treatment.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject
/ Animals
/ Bacteria
/ Bifidobacterium - drug effects
/ Bifidobacterium - growth & development
/ Bifidobacterium - isolation & purification
/ Child
/ Children
/ Diabetes
/ Disease
/ Exposure
/ Female
/ Funding
/ Fusobacteria - growth & development
/ Fusobacteria - isolation & purification
/ Gastrointestinal Microbiome - drug effects
/ Gastrointestinal Microbiome - genetics
/ Humans
/ Immunity
/ Immunoglobulin A, Secretory - analysis
/ Immunoglobulin A, Secretory - immunology
/ Male
/ Mebendazole - administration & dosage
/ Mebendazole - therapeutic use
/ Medicine
/ Medicine and Health Sciences
/ Microbiota (Symbiotic organisms)
/ Salmonella - growth & development
/ Salmonella - isolation & purification
/ Studies
/ Tumors
We currently cannot retrieve any items related to this title. Kindly check back at a later time.